Posted by: APO | 19 July 2016

PEPFAR and DREAMS Partners Announce Winners of the $85 Million DREAMS Innovation Challenge

Today, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR); Janssen Pharmaceutica NV (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson; and ViiV Healthcare announced a combined $85 million investment to support 56 [DREAMS Innovation Challenge]( winners* in 10 sub-Saharan African countries. Of this investment,… Read more on


%d bloggers like this: